Skip to Content

ALE 150 mg (Alecensa 150 mg)

Generic Name: alectinib

Pill with imprint ALE 150 mg is White, Capsule-shape and has been identified as Alecensa 150 mg. It is supplied by Genentech USA, Inc..

Alecensa is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Alecensa 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for ALE 150 mg

Alecensa

Generic Name:
alectinib
Imprint:
ALE 150 mg
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Genentech USA, Inc.
National Drug Code (NDC):
50242-0130

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide